Literature DB >> 8982276

Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines.

T E Cawston1, A J Ellis, H Bigg, V Curry, E Lean, D Ward.   

Abstract

Interleukin-1 (IL-1) in combination with other cytokines can induce a reproducible release of collagen fragments from bovine nasal cartilage in culture. Over 70% of the total collagen is released by day 14 and this release is accompanied by the appearance of collagenolytic activity in the medium that cleaves collagen specifically at the one quarter/three quarter position. Interleukin-4 is able to prevent the release of collagen fragments from the tissue and this is accompanied by a reduced secretion and activation of collagenase (MMP-1) with an increase in tissue inhibitor of metalloproteinases-1 (TIMP-1). IL-4, especially in the presence of IL-1, increased TIMP secretion by bovine nasal cartilage in culture. These results suggest that IL-4 is able to specifically block cartilage collagen resorption by down-regulating the production of collagenase (MMP-1) and up-regulating TIMP-1 by chondrocytes within the cartilage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982276     DOI: 10.1016/s0167-4889(96)00107-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Protective effects of interleukin-4 on tissue destruction and morphological changes of bovine nasal chondrocytes in vitro.

Authors:  Maryam Yadegari; Mahmoud Orazizadeh; Mahmoud Hashemitabar; Ali Khodadadi
Journal:  Iran Biomed J       Date:  2013

2.  Age-related changes in the expression of gelatinase and tissue inhibitor of metalloproteinase genes in mandibular condylar, growth plate, and articular cartilage in rats.

Authors:  Ichiro Takahashi; Kazuyuki Onodera; Jin-Wan Bae; Hidetoshi Mitani; Yasuyuki Sasano; Hideo Mitani
Journal:  J Mol Histol       Date:  2005-10-06       Impact factor: 2.611

3.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

4.  The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1).

Authors:  Eleanor A Woodward; Cecilia M Prêle; Sandra E Nicholson; Tatiana B Kolesnik; Prue H Hart
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

5.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

6.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model.

Authors:  Andrew D Rowan; Wang Hui; Tim E Cawston; Carl D Richards
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

7.  Common variants within the interleukin 4 receptor alpha gene (IL4R) are associated with susceptibility to osteoarthritis.

Authors:  Tracy Forster; Kay Chapman; John Loughlin
Journal:  Hum Genet       Date:  2004-01-24       Impact factor: 4.132

8.  Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Authors:  L A Joosten; E Lubberts; M M Helsen; T Saxne; C J Coenen-de Roo ; D Heinegård; W B van den Berg
Journal:  Arthritis Res       Date:  1999-10-26

9.  Interleukin 13 (IL-13)-regulated expression of the chondroprotective metalloproteinase ADAM15 is reduced in aging cartilage.

Authors:  C Y Yang; A Chanalaris; S Bonelli; O McClurg; G Lorenzatti Hiles; A L Cates; J Miotla Zarebska; T L Vincent; M L Day; S A Müller; S F Lichtenthaler; H Nagase; S D Scilabra; L Troeberg
Journal:  Osteoarthr Cartil Open       Date:  2020-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.